Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases

Details for Australian Patent Application No. 2004267016 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Estrada, Scott A.; Gilson, Charles A Iii; Rey, Max; Sengupta, Dipanjan; Burbaum, Beverly W.; Aytes, Shelley; Weigl, Ulrich; Smith, Brian

Agent FB Rice

Pub. Number AU-B-2004267016

PCT Pub. Number WO2005/019179

Priority 60/512,967 21.10.03 US; 60/479,280 17.06.03 US

Filing date 16 June 2004

Wipo publication date 3 March 2005

Acceptance publication date 24 November 2011

International Classifications

C07C 233/13 (2006.01) Carboxylic acid amides

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/019179 Priority application(s): WO2005/019179

24 November 2011 Application Accepted

  Published as AU-B-2004267016

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004267023-Method of making alkyl esters using glycerin

2004267007-Biaryl heterocyclic compounds and methods of making and using the same